CELL SOURCE INC lost $0.14 per diluted share in fiscal year 2024. This represents an increase of 17.6% from the prior fiscal year. The table below carries 12 fiscal years, from 2013 to 2024, and the quarters CELL SOURCE INC has filed alongside them.
FY2024 annual
EPS (Diluted)-$0.14
YoY+17.6%
Source SEC Filings (10-K/10-Q)Latest period Q1 FY2025, ended Mar 31, 2025ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
CLCS EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was CELL SOURCE INC's diluted earnings per share in fiscal year 2024?
CELL SOURCE INC lost $0.14 per diluted share in fiscal year 2024.
How fast is CELL SOURCE INC's diluted earnings per share growing?
CELL SOURCE INC (CLCS) diluted earnings per share rose by 17.6% year over year, from -$0.17 to -$0.14 in fiscal year 2024.
What was CELL SOURCE INC's diluted earnings per share in the most recent quarter?
CELL SOURCE INC (CLCS) reported -$0.04 in diluted earnings per share in Q1 2025. That is unchanged from the same quarter a year earlier.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what CELL SOURCE INC (CLCS) reported on that line in every period on record.
